A probable atypical skin manifestation of COVID-19 infection
Main Authors: | Mohammad Shahidi Dadras, Omid Zargari, Rozita Abolghasemi, Ayda Bahmanjahromi, Fahimeh Abdollahimajd |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-02-01
|
Series: | Journal of Dermatological Treatment |
Online Access: | http://dx.doi.org/10.1080/09546634.2020.1791309 |
Similar Items
-
Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis
by: Mohammad Reza Pourani, et al.
Published: (2022-05-01) -
Epidermolysis bullosa and the COVID-19 pandemic: challenges and recommendations
by: Hassan Vahidnezhad, et al.
Published: (2022-02-01) -
A case of severe psoriatic erythroderma with COVID-19
by: Fariba Ghalamkarpour, et al.
Published: (2022-02-01) -
Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic
by: Mohammad Shahidi Dadras, et al.
Published: (2022-04-01) -
Management of Pemphigus in COVID-19 Pandemic Era; a Review Article
by: Fahimeh Abdollahimajd, et al.
Published: (2020-04-01)